Global Fc Fusion Protein Market Size, Share, Trends and Forecast 2022-2030

Description

Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure-function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins

This report will focus on Fc fusion protein drugs.

Industry Insights

Due to the COVID-19 pandemic, the global Fc Fusion Protein market size is estimated to be worth US$ 29470 million in 2021 and is forecast to a readjusted size of US$ 60530 million by 2028 with a CAGR of 10.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Fc Fusion Protein market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Fc Fusion Protein landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.

This report focuses on Fc Fusion Protein volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fc Fusion Protein market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Fc Fusion Protein market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Brands Drugs

Biosimilar Drugs

Segment by Application

Autoimmune Disease

Eye Diseases

Diabetes

Hemophilia

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi

Bristol-Myers Squibb

Regeneron

Bayer

Amgen

Pfizer

Eli Lilly and Company

Sobi

Kanghong Pharma

3SBIO

Celgen Biopharma

TABLE OF CONTENT

1 Fc Fusion Protein Market Overview
1.1 Product Overview and Scope of Fc Fusion Protein

1.2 Fc Fusion Protein Segment by Type

1.2.1 Global Fc Fusion Protein Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Brands Drugs

1.2.3 Biosimilar Drugs

1.3 Fc Fusion Protein Segment by Application

1.3.1 Global Fc Fusion Protein Sales Comparison by Application: (2022-2028)

1.3.2 Autoimmune Disease

1.3.3 Eye Diseases

1.3.4 Diabetes

1.3.5 Hemophilia

1.4 Global Fc Fusion Protein Market Size Estimates and Forecasts

1.4.1 Global Fc Fusion Protein Revenue 2017-2028

1.4.2 Global Fc Fusion Protein Sales 2017-2028

1.4.3 Fc Fusion Protein Market Size by Region: 2017 Versus 2021 Versus 2028

2 Fc Fusion Protein Market Competition by Manufacturers

2.1 Global Fc Fusion Protein Sales Market Share by Manufacturers (2017-2022)

2.2 Global Fc Fusion Protein Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Fc Fusion Protein Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Fc Fusion Protein Manufacturing Sites, Area Served, Product Type

2.5 Fc Fusion Protein Market Competitive Situation and Trends

2.5.1 Fc Fusion Protein Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Fc Fusion Protein Players Market Share by Revenue

2.5.3 Global Fc Fusion Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Fc Fusion Protein Retrospective Market Scenario by Region

3.1 Global Fc Fusion Protein Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Fc Fusion Protein Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Fc Fusion Protein Market Facts & Figures by Country

3.3.1 North America Fc Fusion Protein Sales by Country

3.3.2 North America Fc Fusion Protein Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Fc Fusion Protein Market Facts & Figures by Country

3.4.1 Europe Fc Fusion Protein Sales by Country

3.4.2 Europe Fc Fusion Protein Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Fc Fusion Protein Market Facts & Figures by Region

3.5.1 Asia Pacific Fc Fusion Protein Sales by Region

3.5.2 Asia Pacific Fc Fusion Protein Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Fc Fusion Protein Market Facts & Figures by Country

3.6.1 Latin America Fc Fusion Protein Sales by Country

3.6.2 Latin America Fc Fusion Protein Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Fc Fusion Protein Market Facts & Figures by Country

3.7.1 Middle East and Africa Fc Fusion Protein Sales by Country

3.7.2 Middle East and Africa Fc Fusion Protein Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Fc Fusion Protein Historic Market Analysis by Type

4.1 Global Fc Fusion Protein Sales Market Share by Type (2017-2022)

4.2 Global Fc Fusion Protein Revenue Market Share by Type (2017-2022)

4.3 Global Fc Fusion Protein Price by Type (2017-2022)

5 Global Fc Fusion Protein Historic Market Analysis by Application

5.1 Global Fc Fusion Protein Sales Market Share by Application (2017-2022)

5.2 Global Fc Fusion Protein Revenue Market Share by Application (2017-2022)

5.3 Global Fc Fusion Protein Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Sanofi Fc Fusion Protein Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Bristol-Myers Squibb

6.2.1 Bristol-Myers Squibb Corporation Information

6.2.2 Bristol-Myers Squibb Description and Business Overview

6.2.3 Bristol-Myers Squibb Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Bristol-Myers Squibb Fc Fusion Protein Product Portfolio

6.2.5 Bristol-Myers Squibb Recent Developments/Updates

6.3 Regeneron

6.3.1 Regeneron Corporation Information

6.3.2 Regeneron Description and Business Overview

6.3.3 Regeneron Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Regeneron Fc Fusion Protein Product Portfolio

6.3.5 Regeneron Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Bayer Fc Fusion Protein Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Corporation Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Amgen Fc Fusion Protein Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Pfizer Fc Fusion Protein Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Eli Lilly and Company

6.6.1 Eli Lilly and Company Corporation Information

6.6.2 Eli Lilly and Company Description and Business Overview

6.6.3 Eli Lilly and Company Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Eli Lilly and Company Fc Fusion Protein Product Portfolio

6.7.5 Eli Lilly and Company Recent Developments/Updates

6.8 Sobi

6.8.1 Sobi Corporation Information

6.8.2 Sobi Description and Business Overview

6.8.3 Sobi Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Sobi Fc Fusion Protein Product Portfolio

6.8.5 Sobi Recent Developments/Updates

6.9 Kanghong Pharma

6.9.1 Kanghong Pharma Corporation Information

6.9.2 Kanghong Pharma Description and Business Overview

6.9.3 Kanghong Pharma Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Kanghong Pharma Fc Fusion Protein Product Portfolio

6.9.5 Kanghong Pharma Recent Developments/Updates

6.10 3SBIO

6.10.1 3SBIO Corporation Information

6.10.2 3SBIO Description and Business Overview

6.10.3 3SBIO Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.10.4 3SBIO Fc Fusion Protein Product Portfolio

6.10.5 3SBIO Recent Developments/Updates

6.11 Celgen Biopharma

6.11.1 Celgen Biopharma Corporation Information

6.11.2 Celgen Biopharma Fc Fusion Protein Description and Business Overview

6.11.3 Celgen Biopharma Fc Fusion Protein Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Celgen Biopharma Fc Fusion Protein Product Portfolio

6.11.5 Celgen Biopharma Recent Developments/Updates

7 Fc Fusion Protein Manufacturing Cost Analysis

7.1 Fc Fusion Protein Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Fc Fusion Protein

7.4 Fc Fusion Protein Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Fc Fusion Protein Distributors List

8.3 Fc Fusion Protein Customers

9 Fc Fusion Protein Market Dynamics

9.1 Fc Fusion Protein Industry Trends

9.2 Fc Fusion Protein Market Drivers

9.3 Fc Fusion Protein Market Challenges

9.4 Fc Fusion Protein Market Restraints

10 Global Market Forecast

10.1 Fc Fusion Protein Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Fc Fusion Protein by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Fc Fusion Protein by Type (2023-2028)

10.2 Fc Fusion Protein Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Fc Fusion Protein by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Fc Fusion Protein by Application (2023-2028)

10.3 Fc Fusion Protein Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Fc Fusion Protein by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Fc Fusion Protein by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample